Search research articles
Contact Us
Filters
Showing results (301-310 of 436) with videos related to
Page
of 44
Sort By:
RMD Open
|
March 23, 2017
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
Vibeke Strand, Matthew Reaney, Chieh-I Chen, et al.
Arthritis Research & Therapy
|
June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
Vibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.
The Journal of Rheumatology
|
August 3, 2011
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group
Rieke Alten, Christof Pohl, Ernest H Choy, et al.
The Journal of Rheumatology
|
May 8, 2003
MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda
George Wells, Jennifer Anderson, Maarten Boers, et al.
The Journal of Rheumatology
|
August 18, 2009
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)
Clifton O Bingham, Christoph Pohl, Thasia G Woodworth, et al.
Current Rheumatology Reports
|
February 15, 2022
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response
John K Botson, Herbert S B Baraf, Robert T Keenan, et al.
Seminars in Arthritis and Rheumatism
|
December 21, 2023
Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop
Tim Pickles, Mary Cowern, Robin Christensen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 9, 2018
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity
Alfred H J Kim, Vibeke Strand, Deepali P Sen, et al.
Dermatology and Therapy
|
May 30, 2025
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms
Joseph F Merola, Philip J Mease, April W Armstrong, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Page
of 44
Search research articles
Search
Showing results (301-310 of 436) with videos related to
Sort By:
Page
of 44
RMD Open
|
March 23, 2017
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
Vibeke Strand, Matthew Reaney, Chieh-I Chen, et al.
Arthritis Research & Therapy
|
June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
Vibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.
The Journal of Rheumatology
|
August 3, 2011
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group
Rieke Alten, Christof Pohl, Ernest H Choy, et al.
The Journal of Rheumatology
|
May 8, 2003
MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda
George Wells, Jennifer Anderson, Maarten Boers, et al.
The Journal of Rheumatology
|
August 18, 2009
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)
Clifton O Bingham, Christoph Pohl, Thasia G Woodworth, et al.
Current Rheumatology Reports
|
February 15, 2022
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response
John K Botson, Herbert S B Baraf, Robert T Keenan, et al.
Seminars in Arthritis and Rheumatism
|
December 21, 2023
Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop
Tim Pickles, Mary Cowern, Robin Christensen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 9, 2018
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity
Alfred H J Kim, Vibeke Strand, Deepali P Sen, et al.
Dermatology and Therapy
|
May 30, 2025
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms
Joseph F Merola, Philip J Mease, April W Armstrong, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Page
of 44